Publications by authors named "Mark Litzow"

100Publications

Risk of relapse in patients receiving azithromycin after allogeneic HSCT.

Bone Marrow Transplant 2020 Oct 31. Epub 2020 Oct 31.

Department of Hematology, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-020-01095-8DOI Listing
October 2020

Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report.

Blood Adv 2020 Jul;4(13):3180-3190

Center for International Blood and Marrow Transplant Research, Department of Medicine, and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2019001266DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362362PMC
July 2020

Advances in Supportive Care for Acute Lymphoblastic Leukemia.

Curr Hematol Malig Rep 2020 Aug;15(4):276-293

Division of Hematology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-020-00585-2DOI Listing
August 2020

A Prospective Survey of Outpatient Medication Adherence in Adult Allogeneic Hematopoietic Stem Cell Transplantation Patients.

Biol Blood Marrow Transplant 2020 Sep 4;26(9):1627-1634. Epub 2020 Jun 4.

Department of Pharmacy Services, Mayo Clinic Hospital, Rochester, Minnesota. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2020.05.020DOI Listing
September 2020

The increasing complexity of the management of core-binding factor acute myeloid leukemia.

Authors:
Mark R Litzow

Haematologica 2020 Jun;105(6):1475-1477

Division of Hematology and Transplant Center, Mayo Clinic Rochester, Rochester, MN, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2020.249110DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271610PMC
June 2020

A novel PrECOG (PrE0901) dose-escalation trial using eltrombopag: enhanced platelet recovery during consolidation therapy in acute myeloid leukemia.

Leuk Lymphoma 2020 09 30;61(9):2191-2199. Epub 2020 May 30.

Department of Medicine, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2020.1762878DOI Listing
September 2020

Incidence, Risk Factors for and Outcomes of Transplant-Associated Thrombotic Microangiopathy.

Br J Haematol 2020 Jun 2;189(6):1171-1181. Epub 2020 Mar 2.

CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16457DOI Listing
June 2020

Management of toxicities associated with novel immunotherapy agents in acute lymphoblastic leukemia.

Ther Adv Hematol 2020 20;11:2040620719899897. Epub 2020 Jan 20.

Division of Hematology and Bone Marrow Transplant, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2040620719899897DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6971963PMC
January 2020

Systemic methotrexate absorption in a patient receiving intrathecal chemotherapy for acute lymphoblastic leukemia.

Leuk Lymphoma 2020 04 13;61(4):993-995. Epub 2019 Dec 13.

Division of Hematology (W10), Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1702184DOI Listing
April 2020

Inhibition of the mutated c-KIT kinase in AML1-ETO-positive leukemia cells restores sensitivity to PARP inhibitor.

Blood Adv 2019 12;3(23):4050-4054

Sol Sherry Thrombosis Research Center and Fels Institute for Cancer Research and Molecular Biology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2019000756DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963253PMC
December 2019

Two-dimensional speckle-tracking strain detects subclinical cardiotoxicity in older patients treated for acute myeloid leukemia.

Echocardiography 2019 11 8;36(11):2033-2040. Epub 2019 Nov 8.

Division of Cardiovascular Medicine, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/echo.14518DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6874906PMC
November 2019

Protein lysine 43 methylation by EZH1 promotes AML1-ETO transcriptional repression in leukemia.

Nat Commun 2019 11 7;10(1):5051. Epub 2019 Nov 7.

Department of Hematology-Oncology, International Cancer Center, Shenzhen University General Hospital, Shenzhen University Health Science Center, 1098 Xueyuan Ave, 518060, Shenzhen, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-019-12960-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838331PMC
November 2019

PD-1/PD-L1 expression in extramedullary lesions of acute myeloid leukemia.

Leuk Lymphoma 2019 Oct 12:1-4. Epub 2019 Oct 12.

Division of Hematology, Department of Internal Medicine, Mayo Clinic , Rochester , MN , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1675880DOI Listing
October 2019

Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research.

Haematologica 2020 05 26;105(5):1329-1338. Epub 2019 Sep 26.

Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota Medical Center, Minneapolis, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2019.220756DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193485PMC
May 2020

Ibrutinib-Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia.

N Engl J Med 2019 08;381(5):432-443

From Stanford University, Stanford (T.D.S., S.E.C.), the University of California, Irvine, Medical Center, Orange (S.O.), and Kaiser Permanente National Cancer Institute Community Oncology Research Program (NCORP)-Permanente Medical Group, Oakland (C.C.Z.) - all in California; Dana-Farber Cancer Institute, Boston (X.V.W., R.M.S.); Mayo Clinic, Rochester (N.E.K., C.A.H., J.F.L., M.L.), and Minnesota Oncology, Burnsville (A.K.S.) - both in Minnesota; Northwell Health Cancer Institute, Donald and Barbara Zucker School of Medicine at Hofstra-Northwell, Lake Success (J.B.), and University of Rochester, Rochester (P.M.B.) - both in New York; Mayo Clinic, Phoenix, AZ (D.F.J., E.B.); Washington University School of Medicine, St. Louis (A.F.C.); Memorial Sloan Kettering Cancer Center, New York (A.R.M., M.T.); Aurora Cancer Care, West Allis, WI (M.P.M.); National Cancer Institute, Bethesda, MD (R.F.L.); and the University of Alabama, Tuscaloosa (H.E.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1817073DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6908306PMC
August 2019

Recent advances in the biology and treatment of B-cell acute lymphoblastic leukemia.

Blood Lymphat Cancer 2018 25;8:47-61. Epub 2018 Sep 25.

Division of Hematology, Mayo Clinic, Rochester, MN, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/BLCTT.S170351DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467350PMC
September 2018

Risks and Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies in Patients with HIV Infection.

Biol Blood Marrow Transplant 2019 08 26;25(8):e260-e267. Epub 2019 Mar 26.

Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.03.021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144878PMC
August 2019

No free rides: management of toxicities of novel immunotherapies in ALL, including financial.

Hematology Am Soc Hematol Educ Program 2018 11;2018(1):25-34

Division of Hematology and Bone Marrow Transplant, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2018.1.25DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6246022PMC
November 2018

Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL.

N Engl J Med 2018 12 1;379(26):2517-2528. Epub 2018 Dec 1.

From Ohio State University Comprehensive Cancer Center, Columbus (J.A.W., A.S.R., N.A.H., W.Z., K.A.R., G.L., J.S.B., H.G.O., J.C.B.); the Alliance Statistics and Data Center (A.S.R., A.M.B., B.M.-E., B.F., S.J.M.), Mayo Clinic (W.D., S.A.P., M.L.), Rochester, MN; Washington University School of Medicine, St. Louis (N.L.B.); Duke Cancer Institute, Duke University Medical Center, Durham (D.M.B., H.E.), and First Health of the Carolinas Cancer Center, Pinehurst (C.K.) - both in North Carolina; the University of Rochester Medical Center, Rochester, NY (P.M.B.); Stanford University School of Medicine, Stanford (S.C.), and the City of Hope Comprehensive Cancer Center, Duarte (A.H.) - both in California; Dana-Farber Partners CancerCare (J.R.B., R.M.S.) and the Massachusetts General Hospital Cancer Center (J.S.A.) - both in Boston; Fort Wayne Medical Oncology and Hematology, Fort Wayne, IN (S.N.); University of Chicago Comprehensive Cancer Center (R.A.L.) and Loyola University Chicago (S.E.S.) - both in Chicago; the University of Calgary, Tom Baker Cancer Centre, Calgary, AB, Canada (C.O.); and the Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD (R.F.L.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1812836DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325637PMC
December 2018

No free rides: management of toxicities of novel immunotherapies in ALL, including financial.

Blood Adv 2018 11;2(22):3393-3403

Division of Hematology and Bone Marrow Transplant, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2018020198DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258912PMC
November 2018

Allogeneic transplantation for patients with Philadelphia chromosome positive acute lymphoblastic leukemia: Is it imperative in the tyrosine kinase inhibitor era?

Authors:
Mark R Litzow

Best Pract Res Clin Haematol 2018 12 20;31(4):357-360. Epub 2018 Sep 20.

Division of Hematology and Blood and Marrow Transplant, Mayo Clinic, 200 1st Street South West, Rochester, MN 55905, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2018.09.004DOI Listing
December 2018

Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study.

Biol Blood Marrow Transplant 2019 04 10;25(4):699-711. Epub 2018 Nov 10.

Center for International Blood and Marrow Transplant Research, Minneapolis, Minnesota; National Marrow Donor Program/Be the Match, Minneapolis, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.11.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6453753PMC
April 2019

Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors.

Haematologica 2019 04 31;104(4):844-854. Epub 2018 Oct 31.

Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI.

View Article

Download full-text PDF

Source
http://www.haematologica.org/lookup/doi/10.3324/haematol.201
Publisher Site
http://dx.doi.org/10.3324/haematol.2018.200121DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442962PMC
April 2019

A dynamic N-methyladenosine methylome regulates intrinsic and acquired resistance to tyrosine kinase inhibitors.

Cell Res 2018 11 8;28(11):1062-1076. Epub 2018 Oct 8.

The Hormel Institute, University of Minnesota, Austin, MN, 55912, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41422-018-0097-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6218444PMC
November 2018

Recent Advances in the Biology and Treatment of T Cell Acute Lymphoblastic Leukemia.

Curr Hematol Malig Rep 2018 08;13(4):265-274

Division of Hematology, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-018-0455-9DOI Listing
August 2018